Detailed price information for Regen Biopharma Inc (RGBP) from The Globe and Mail including charting and trades.

Detailed price information for Regen Biopharma Inc (RGBP) from The Globe and Mail including charting and trades.

Becton, Dickinson and Company (NYSE:BDX) Q1 2026 Earnings Call Transcript February 9, 2026 Becton, Dickinson and Company beats earnings expectations. Reported EPS is $2.91, expectations were $2.81.

Becton, Dickinson and Company delivered a Q1 2026 earnings beat, with $2.91 non-GAAP EPS and $5.25B revenue, surpassing expectations. Learn more about BDX stock here.

As a reminder, beginning October 1, we began operating under our previously disclosed new Becton, Dickinson and Company segment structure that includes Medical Essentials, Connected Care, Biopharma ...

Concluding the interaction, Dr Jitendra Singh said the Budget reflects a mission-oriented approach, where research, ...

Becton, Dickinson and Company (NYSE:BDX) reported first fiscal quarter 2026 results that management said were stronger than expected, while also highlighting the completion of its previously announced ...

Healthcare leaders hail transformative 'BioPharma Shakti' & regional hub initiatives proposed in budget: Our Bureau, Chennai Monday, February 2, 2026, 13:15 Hrs [IST] The Union Bu ...

Affordable drugs, vaccines and diagnostics, supported by domestic biomanufacturing, would be a major social and economic ...

India, Feb. 3 -- There is a definite shift in policy and strategy from last year's populist and consumption spend led economy ...

India, Feb. 2 -- Union Minister of State (Independent Charge) for Science & Technology and Earth Sciences, and Minister of ...